Cited by 93Pancreatic function and diabetesGenetic Associations and EpidemiologyDiabetes and associated disorders

The Pathogenesis of Type II Diabetes Mellitus:A Polygenic Disease

Sacks, David B., McDonald, Jay M.·1996·American Journal of Clinical Pathology

Abstract

Diabetes mellitus is the most common endocrine disease, consuming almost 15% of annual health care expenditures in the United States. The focus of this review is on type II (non-insulin-dependent) diabetes mellitus, which accounts for approximately 90% of diabetic patients. The current understanding of the pathogenesis of type II diabetes is multifaceted. Complex defects in both insulin action and insulin secretion produce the metabolic derangements responsible for the disease. The pathophysiology is the result of a combination of polygene defects and environmental factors. The search for the responsible gene or genes is described and several candidate genes are discussed. Diabetogenes are addressed in the context of type II diabetes representing a prototype for the identification of the genetic basis of common diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ajcp/105.2.149

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Type 2 diabetes is a heterogenous polygenic disease with both resistance to the action of insulin and defective insulin secretion.

    “Type 2 diabetes is a heterogenous polygenic disease with both resistance to the action of insulin and defective insulin secretion (4,5).”
  • Measurement of C-peptide can aid in instances in which it is difficult to differentiate between the diagnosis of type 1 and type 2 diabetes.

    “Measurement of the C-peptide, in the fasting state or in response to intravenous glucagon, can aid in instances in which it is difficult to differentiate between the diagnosis of type 1 and type 2 diabetes (5,511).”

    From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [5]

    The Loss of β-Cell Function section discusses insulin responses to intravenous glucose and other secretagogues, but not C-peptide testing for distinguishing type 1 from type 2 diabetes. Searches for C-peptide and diagnostic differentiation found no passage addressing that use; the indexed passages provide no page number. (LLM, conf=0.74)

    Experimental — accuracy not yet measured
  • Type 2 diabetes mellitus is caused by a combination of insulin resistance and inadequate insulin secretion.

    “Type 2 diabetes mellitus, formerly known as non-IDDM or adultonset diabetes, is caused by a combination of insulin resistance and inadequate insulin secretion (3,4).”
  • Type 2 diabetes is a heterogeneous polygenic disorder involving both insulin resistance and impaired insulin secretion.

    “Type 2 diabetes is a heterogeneous polygenic disease with both resistance to the action of insulin and defective insulin secretion (3,4).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 7

  1. [9]9. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543-546.
  2. [15]15. Flier JS. Syndromes of insulin resistance: From patient to gene and back again. £>/a6<?/« 1992;41:1207-1219.
  3. [17]17. Taylor R. Insulin action 1991. Clin Endocrinol 1991;34:159-171.
  4. [23]23. Elbein SC, Hoffman MD, Bragg KL, Mayorga RA. The genetics of NIDDM. An update. Diabetes Care 1994; 17:1523-1533.
  5. [24]24. Barnett AH, EfT C, Leslie RD, Pyke DA. Diabetes in identical twins: A study of 200 pairs. Diabetologia 1981 ;20:87-93.
  6. [29]29. Neel JV. Diabetes mellitus: A geneticists's nightmare. In: Creutz- feldt W, Kobberling J, Neel JV, eds. The Genetics of Diabetes. New York: Springer, 1976, pp 1-11.
  7. [40]40. Grant PJ, Stickland MH, Mansfield MW. Insulin receptor sub- strate-1 gene and cardiovascular risk factors in NIDDM [Let- ter]. Lancet 1995;346:841-842.

Cited by

Sorted by citations

Authors
Sacks, D. B., & McDonald, J. M.
Affiliations
  • Brigham and Women's Hospital (US)
  • University of Alabama at Birmingham (US)
Venue
American Journal of Clinical Pathology
Published
1996-02-01
Volume
105
Issue
2
Pages
149-156
ISSN
  • 0002-9173 (ISSN-L)
  • 1943-7722
OpenAlex
W25782933
Cited by
93
References
38
Citations by year
2025: 4 · 2024: 1 · 2023: 7 · 2022: 2 · 2021: 5 · 2020: 4 · 2019: 2 · 2018: 4 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 2 · 2013: 4 · 2012: 4
FWCI
1.21
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Clinical Pathology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
type 2 diabetes, pathogenesis, polygenic disease, insulin resistance, insulin secretion defect, candidate genes, genetic susceptibility, environmental factors
MeSH terms
Insulin Secretion, Aged, Diabetes Mellitus, Type 2, Glucose, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Phosphorylation, Proteins, Receptor, Insulin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review